Austin,TX , Sensor Bio, the continuous biometric signal infrastructure platform built for clinical, enterprise, and AI ...

The proceeds from the financing will fund Latus Bio’s operations through key clinical milestones.

Innovative “virus-like particle” platform technology significantly expands the agricultural application potential of ...

Revenue was $19.1 million in the first quarter of 2026, an increase of 3% compared to the same period in 2025 with unit growth of 13% compared to the same period in 2025. The increase was primarily ...

Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...

Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in gene-editing technology. The move aims to explore high-growth new business ...